SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GMED
GMED 60.39-0.5%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Lenis Warren who wrote (17)1/3/1997 11:16:00 AM
From: Cong Cao   of 63
 
The article was published on Dec. 18, 1996, I believe, which indicates that the GMED stock is fairly valued at about $8-10. I remember that the Company stated in its news releases from July to November that it was going to file to FDA to conduct the Phase II clinical trial by the end of 1996. It is overdue up to this point, but I am expecting it soon.

Although the Company is still in the stage of research, it has enough cash to go through the process until 1999. Maybe the information is not accurate, please visit the Company's home page. I am going to hold on the stock for a while.

Cong Cao
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext